A new ablation treatment for atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new type of ablation (pulsed field ablation) for people with atrial fibrillation who haven't gotten enough relief from medication alone. It aims to see if isolating the superior vena cava along with the pulmonary veins is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with atrial fibrillation (confirmed by an EKG or heart monitor in the last year)
- You have tried at least one heart rhythm medication that didn't work well or caused side effects
- You are willing to use a pulsed field ablation system that is approved in China
- You have not had any prior surgery or catheter procedure for an irregular heartbeat
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding extra ablation to the standard treatment for atrial fibrillation improves outcomes for patients who do not have damaged heart tissue. It may help people with AF who haven't had ablation before and have a specific area in their heart that could be targeted.
This trial tests whether reusing special catheters to treat atrial fibrillation is safe, effective, and better for costs and the environment. It may help people with atrial fibrillation who need a procedure called pulmonary vein isolation.
This study tests a new balloon catheter that uses pulsed electric fields to isolate the veins that carry blood from your lungs to your heart. It may be a treatment option for people with atrial fibrillation who are scheduled for an ablation procedure.
This study tests a new way to treat atrial fibrillation (AFib) using pulsed electrical energy to target the heart tissue that causes the irregular rhythm. It aims to see if this method is safe and effective for people having their first such treatment.
This study tests a new way to do a heart procedure (catheter ablation) for people with ongoing atrial fibrillation (an irregular heartbeat). It uses pulsed-field energy to create a block in the heart that stops abnormal electrical signals. The goal is to improve the procedure's success and reduce risks.
This trial tests a new procedure that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat. The goal is to see if this approach is safe and effective in restoring a normal heart rhythm.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.